4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-26-000089
Executive Chair sold 26,759 shares at $72.00 ($1,926,648)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SAYER KEVIN R Executive Chair | 2026-05-21 | Sale 10b5-1 | −26,759 | $72.00 | $1,926,648 | 382,482 | D: show line 1 in the form |
| Open-market sales · 26,759 sh · avg $72.00 · $1,926,648 | |||||||
Loading xslF345X06/wk-form4_1779826702.xml…